-
1
-
-
33344458573
-
International consensus statementon an update of the preliminary classification criteria for antiphospholipid syndrome (APS)
-
S. Miyakis, M.D. Lockshin, D. Atsumi, W. Branch, R.L. Brey, and R. Cervera International consensus statementon an update of the preliminary classification criteria for antiphospholipid syndrome (APS) J Thromb Haemost 4 2006 295 306
-
(2006)
J Thromb Haemost
, vol.4
, pp. 295-306
-
-
Miyakis, S.1
Lockshin, M.D.2
Atsumi, D.3
Branch, W.4
Brey, R.L.5
Cervera, R.6
-
2
-
-
79251489118
-
Mechanisms of anti-phospholipid antibody formation and action
-
P.G. de Groot Mechanisms of anti-phospholipid antibody formation and action Thromb Res 127 suppl 3 2011 S40 S42
-
(2011)
Thromb Res
, vol.127
, Issue.SUPPL. 3
-
-
De Groot, P.G.1
-
3
-
-
79958045457
-
The association between antiphospholipid antibodies and placenta mediated complications: A systematic review and meta-analysis
-
K. Abou-Nassar, M. Carrier, T. Ramsay, and M.A. Rodger The association between antiphospholipid antibodies and placenta mediated complications: A systematic review and meta-analysis Thromb Res 128 2011 77 85
-
(2011)
Thromb Res
, vol.128
, pp. 77-85
-
-
Abou-Nassar, K.1
Carrier, M.2
Ramsay, T.3
Rodger, M.A.4
-
4
-
-
0037148520
-
Complement C3 activation is required for antiphospholipid antibody-induced fetal loss
-
DOI 10.1084/jem.200116116
-
V.M. Holers, G. Girardi, L. Mo, J.M. Guthridge, H. Molina, and S.S. Pierangeli Complement C3 activation is required for antiphospholipid antibody-induced fetal loss J Exp Med 195 2002 211 220 (Pubitemid 34461265)
-
(2002)
Journal of Experimental Medicine
, vol.195
, Issue.2
, pp. 211-220
-
-
Michael Holers, V.1
Girardi, G.2
Mo, L.3
Guthridge, J.M.4
Molina, H.5
Pierangeli, S.S.6
Espinola, R.7
Xiaowei, L.E.8
Mao, D.9
Vialpando, C.G.10
Salmon, J.E.11
-
6
-
-
0001145459
-
A haemorrhage disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus
-
C.L. Conley, and R.C. Hartmann A haemorrhage disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus J Clin Invest 31 1952 621 622
-
(1952)
J Clin Invest
, vol.31
, pp. 621-622
-
-
Conley, C.L.1
Hartmann, R.C.2
-
7
-
-
50549207211
-
Thrombosis in systemic lupus erythematosus despite circulating anticoagulants
-
E.J.W. Bowie, J.H. Thompson, C.A. Pascuzzi, and C.A. Owen Thrombosis in systemic lupus erythematosus despite circulating anticoagulants J Lab Clin Med 62 1963 416 430
-
(1963)
J Lab Clin Med
, vol.62
, pp. 416-430
-
-
Bowie, E.J.W.1
Thompson, J.H.2
Pascuzzi, C.A.3
Owen, C.A.4
-
8
-
-
0023434038
-
Syndrome of the black swan
-
E.N. Harris Syndrome of the black swan Br J Rheumatol 26 1987 324 326
-
(1987)
Br J Rheumatol
, vol.26
, pp. 324-326
-
-
Harris, E.N.1
-
9
-
-
0033512274
-
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International Workshop
-
DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
-
W.A. Wilson, A.E. Gharavi, T. Koike, M.D. Lockshin, D.W. Branch, and R.L. Brey International concensus statement on preliminary classification criteria for definite antiphospholipid syndrome Arthritis Rheum 42 1999 1309 1311 (Pubitemid 30265586)
-
(1999)
Arthritis and Rheumatism
, vol.42
, Issue.7
, pp. 1309-1311
-
-
Wilson, W.A.1
Gharavi, A.E.2
Koike, T.3
Lockshin, M.D.4
Ware Branch, D.5
Piette, J.-C.6
Brey, R.7
Derksen, R.8
Nigel Harris, E.9
Hughes, G.R.V.10
Triplett, D.A.11
Khamashta, M.A.12
-
11
-
-
70350004861
-
Update of the guidelines for lupus anticoagulant detection
-
V. Pengo, A. Tripodi, G. Reber, J.H. Rand, T.L. Ortel, and M. Galli Update of the guidelines for lupus anticoagulant detection J Thromb Haemost 7 2009 1737 1740
-
(2009)
J Thromb Haemost
, vol.7
, pp. 1737-1740
-
-
Pengo, V.1
Tripodi, A.2
Reber, G.3
Rand, J.H.4
Ortel, T.L.5
Galli, M.6
-
12
-
-
79959382588
-
Antiphospholipid syndrome: Laboratory detection, mrechanisms of action and treatment
-
A. Tripodi, P.G. de Groot, and V. Pengo Antiphospholipid syndrome: laboratory detection, mrechanisms of action and treatment J Intern Med 270 2011 110 122
-
(2011)
J Intern Med
, vol.270
, pp. 110-122
-
-
Tripodi, A.1
De Groot, P.G.2
Pengo, V.3
-
13
-
-
77955711196
-
Standardized antigen preparation to achieve comparability of anti-β2-glycoprotein i assays
-
C. Müller, A. Schlitiger, G. Balling, U. Steigerwald, P.B. Luppa, and M. Thaler Standardized antigen preparation to achieve comparability of anti-β2-glycoprotein I assays Thromb Res 126 2010 e102 e109
-
(2010)
Thromb Res
, vol.126
-
-
Müller, C.1
Schlitiger, A.2
Balling, G.3
Steigerwald, U.4
Luppa, P.B.5
Thaler, M.6
-
14
-
-
79957589018
-
Standadization of lupus anticoagulant. Feasibility study of a calibration model to minimize between-method variability
-
A. Tripodi, V. Chantarangkul, M. Clerici, C. Palmucci, E. Bison, and A. Banzato Standadization of lupus anticoagulant. Feasibility study of a calibration model to minimize between-method variability Thromb Res 127 2011 589 594
-
(2011)
Thromb Res
, vol.127
, pp. 589-594
-
-
Tripodi, A.1
Chantarangkul, V.2
Clerici, M.3
Palmucci, C.4
Bison, E.5
Banzato, A.6
-
15
-
-
1842296917
-
Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies
-
J. Musiał, J. Swadźba, M. Jankowski, M. Grzywacz, S. Bazan-Socha, and A. Szczeklik Thrombin generation measured ex vivo following microvascular injury is increased In SLE patients with antiphospholipid-protein antibodies Thromb Haemost 78 1997 1173 1177 (Pubitemid 27464581)
-
(1997)
Thrombosis and Haemostasis
, vol.78
, Issue.4
, pp. 1173-1177
-
-
Musial, J.1
Swadzba, J.2
Jankowski, M.3
Grzywacz, M.4
Bazan-Socha, S.5
Szczeklik, A.6
-
16
-
-
0036228886
-
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
-
DOI 10.1002/art.10187
-
R. Cerevera, U.C. Piette, J. Font, M.A. Khamashta, Y. Shoenfeld, and M.T. Camps Antiphospholipid syndrome. Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients Arthritis Rheum 46 2002 1019 1027 (Pubitemid 34303815)
-
(2002)
Arthritis and Rheumatism
, vol.46
, Issue.4
, pp. 1019-1027
-
-
Cervera, R.1
Piette, J.-C.2
Font, J.3
Khamashta, M.A.4
Shoenfeld, Y.5
Camps, M.T.6
Jacobsen, S.7
Lakos, G.8
Tincani, A.9
Kontopoulou-Griva, I.10
Galeazzi, M.11
Meroni, P.L.12
Derksen, R.H.W.M.13
De Groot, P.G.14
Gromnica-Ihle, E.15
Baleva, M.16
Mosca, M.17
Bombardieri, S.18
Houssiau, F.19
Gris, J.-C.20
Quere, I.21
Hachulla, E.22
Vasconcelos, C.23
Roch, B.24
Fernandez-Nebro, A.25
Boffa, M.-C.26
Hughes, G.R.V.27
Ingelmo, M.28
more..
-
17
-
-
0037370733
-
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature
-
DOI 10.1182/blood-2002-02-0441
-
M. Galli, D. Luciani, G. Bertolini, and T. Barbui Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature Blood 101 2003 1827 1832 (Pubitemid 36237580)
-
(2003)
Blood
, vol.101
, Issue.5
, pp. 1827-1832
-
-
Galli, M.1
Luciani, D.2
Bertolini, G.3
Barbui, T.4
-
18
-
-
79955815184
-
Risk factors for a first thrombotic event in antiphospholipid antibody carriers: A prospective multicentre follow-up study
-
A. Ruffatti, T. Del Ross, M. Ciprian, M.T. Bertero, S. Sciascia, and S. Scarpato Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study Ann Rheum Dis 70 2011 1083 1086
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 1083-1086
-
-
Ruffatti, A.1
Del Ross, T.2
Ciprian, M.3
Bertero, M.T.4
Sciascia, S.5
Scarpato, S.6
-
19
-
-
78650963444
-
An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein i antibodies
-
B. De Laat, R.H.W.M. Derksen, G. Reber, J. Musial, J. Swadzba, and B. Bozic An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein I antibodies J Thromb Haemost 9 2011 149 153
-
(2011)
J Thromb Haemost
, vol.9
, pp. 149-153
-
-
De Laat, B.1
Derksen, R.H.W.M.2
Reber, G.3
Musial, J.4
Swadzba, J.5
Bozic, B.6
-
20
-
-
70449390005
-
The association between circulationg antibodies against domain i of beta2-glycoprotein i and thrombosis: An international multicenter study
-
B. de Laat, V. Pengo, I. Pabinger, J. Musial, A.E. Voskuyl, and I.E.M. Bultink The association between circulationg antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study J Thromb Haemost 7 2009 1767 1773
-
(2009)
J Thromb Haemost
, vol.7
, pp. 1767-1773
-
-
De Laat, B.1
Pengo, V.2
Pabinger, I.3
Musial, J.4
Voskuyl, A.E.5
Bultink, I.E.M.6
-
21
-
-
34548083293
-
Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases
-
DOI 10.1111/j.1538-7836.2007.02669.x
-
J. Swadzba, T. Iwaniec, A. Szczeklik, and J. Musial Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases J Thromb Haemost 5 2007 1883 1889 (Pubitemid 47288946)
-
(2007)
Journal of Thrombosis and Haemostasis
, vol.5
, Issue.9
, pp. 1883-1889
-
-
Swadzba, J.1
Iwaniec, T.2
Szczeklik, A.3
Musial, J.4
-
22
-
-
74749086117
-
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
-
V. Pengo, A. Ruffatti, C. Legnani, P. Gresele, D. Barcellona, and N. Erba Clinical course of high-risk patients diagnosed with antiphospholipid syndrome J Thromb Haemost 8 2010 237 242
-
(2010)
J Thromb Haemost
, vol.8
, pp. 237-242
-
-
Pengo, V.1
Ruffatti, A.2
Legnani, C.3
Gresele, P.4
Barcellona, D.5
Erba, N.6
|